Cbd Enriched Lines

CBD-enriched lines represent cannabis genetics deliberately selected or bred to express elevated cannabidiol (CBD) relative to THC, a trait that emerged prominently in the 1990s–2000s as breeders stabilized high-CBD phenotypes. These lines typically carry genetic markers that favor CBDA synthase expression while suppressing or moderating THCA synthase activity, resulting in chemotype profiles often ranging from 1:1 CBD:THC ratios to near-complete CBD dominance (>15% CBD, <0.5% THC in some selections). Lineage records frequently report foundation work from Swiss landrace material, Eastern European hemp genetics, and deliberate crosses with high-CBD cultivars like Cannatonic and Charlotte's Web ancestry. CBD-enriched breeding has become foundational to regulatory-compliant hemp programs and therapeutic-focused cultivar development worldwide. Understanding these lines' genetic architecture—

Breeders working with CBD-enriched lines prioritize stable cannabinoid ratios through backcrossing to known high-CBD parents and marker-assisted selection for CBDA synthase genotypes. These genetics serve as foundation stock for crossing programs targeting specific CBD:THC ratios, terpene enhancement, or agronomic traits while maintaining cannabinoid consistency.